Physician profile
Kristen Daniel
NPI 1699080416
$2,586.96
in general payments reported to CMS, 2019-2025
15 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $170 · 2021: $254 · 2022: $824 · 2023: $499 · 2024: $222 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $781.63 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $544.15 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $388.98 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Coopervision INC. | $285.67 | 2019-2024 | Cvi Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $104.50 | 2019-2021 | |
| Horizon Therapeutics Plc | $98.71 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $62.27 | 2019 | |
| Oyster Point Pharma, INC. | $60.23 | 2023 | Tyrvaya |
| Optos, INC. | $56.04 | 2020 | |
| Allergan, INC. | $53.58 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $41.38 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $37.08 | 2021-2024 | |
| Abbvie INC. | $29.80 | 2023 | Alphagan P, Lumigan |
| Coopersurgical, INC. | $26.22 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $16.72 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.